BMC Neurol

1. RAGAB S, Fouda BH, Sarhan AA, Abbas A, et al
   Multiple sclerosis patients' journey delay in diagnosis and treatment: a multicenter study.
   BMC Neurol. 2025;25:377.
   

   >> Share

   
   
2. SANTAGOSTINO BARBONE A, De Grandis E, Giacomini T, Buratti S, et al
   Refractory "status dyskineticus" in a child with post-herpes simplex virus 1 N-methyl-D-aspartate receptor encephalitis: a case report.
   BMC Neurol. 2025;25:368.
   

   >> Share

   
   

   
   Brain

3. ESSER D, Muller-Miny L, Heming M, Paunovic M, et al
   Activated alphabeta T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis.
   Brain. 2025;148:3170-3183.
   

   >> Share

   
   

   
   Diabetes Res Clin Pract

4. PALIARES IC, Dualib PM, Teixeira Aroucha PM, Noronha Torres LS, et al
   Cardiovascular risk stratification in an ethnically mixed population with type 1 diabetes mellitus: comparison of the Steno Type 1 Risk Engine with the Scottish-Swedish risk model.
   Diabetes Res Clin Pract. 2025;227:112386.
   

   >> Share

   
   
5. MILLUZZO A, Quaranta G, Manuella L, Sceusa G, et al
   Sarcopenia in type 1 diabetes mellitus: a systematic review.
   Diabetes Res Clin Pract. 2025;227:112399.
   

   >> Share

   
   
6. GILLON-KEREN M, Propper-Lewinsohn T, David M, Fayman G, et al
   Mediterranean diet adherence among adolescents with type 1 diabetes: Insights into dietary patterns, glycemic control, and gender differences.
   Diabetes Res Clin Pract. 2025;227:112400.
   

   >> Share

   
   
7. ELLIS DA, Carcone AI, Buggs-Saxton C, Bhan A, et al
   Effects of individual, health system and neighborhood risks on diabetes health outcomes among emerging adults with type 1 diabetes.
   Diabetes Res Clin Pract. 2025;227:112415.
   

   >> Share

   
   
8. LOBLEY K, Youde LS, Vandervliet L, Wong HHT, et al
   Responsive feeding, diabetes management, weight status and diet quality in a culturally diverse group of 1-5-year-old Australian children with type 1 diabetes.
   Diabetes Res Clin Pract. 2025;227:112402.
   

   >> Share

   
   
9. GARCIA-HERMOSO A, Huerta-Uribe N, Hormazabal-Aguayo I, Munoz-Pardeza J, et al
   Sex-specific thresholds of peak oxygen consumption for detecting cardiometabolic risk in children and adolescents with type 1 diabetes.
   Diabetes Res Clin Pract. 2025;227:112410.
   

   >> Share

   
   
10. COCKING E, Daher J, Alabbood M
    New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2025;227:112417.
    

    >> Share

    
    

    
    Intern Med

11. SHINZATO T, Nagai K, Hoshino Y, Fujiwara Y, et al
    Immunoglobulin A Nephropathy in a Kidney Transplant Recipient with Kabuki Syndrome.
    Intern Med. 2025;64:2619-2625.
    

    >> Share

    
    
12. OKURO K, Hashimoto H, Morita K, Noshi Y, et al
    Anamorelin Induced Hyperglycemia in a Patient with Type 1 Diabetes by Stimulating Growth Hormone Secretion.
    Intern Med. 2025;64:2592-2596.
    

    >> Share

    
    

    
    J Autoimmun

13. SONG Y, Zhou B, Long J, Peng Y, et al
    Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs.
    J Autoimmun. 2025;156:103475.
    

    >> Share

    
    

    
    J Neuroimmunol

14. KIMURA A, Takekoshi A, Maekawa Y, Tanaka K, et al
    Serum neurofilament light chain as a prognostic biomarker of glial fibrillary acidic protein autoimmunity.
    J Neuroimmunol. 2025;408:578739.
    

    >> Share

    
    
15. ZHAO M, Li J, Jin L, Luo Z, et al
    Next-generation approaches in autoimmune encephalitis diagnosis: A multi-omics perspective.
    J Neuroimmunol. 2025;408:578740.
    

    >> Share

    
    
16. TANG Y, Wang H, Wang X, Yan Z, et al
    Characterizing the relationship between FLAIR hyper-rim lesions and paramagnetic rim lesions in multiple sclerosis.
    J Neuroimmunol. 2025;408:578738.
    

    >> Share

    
    

    
    J Neurol

17. KONG L, Tan X, Wang H, Cao L, et al
    Progressive retinal and microvascular neurodegeneration in neuromyelitis optica spectrum disorders: a longitudinal SS-OCT/OCTA study.
    J Neurol. 2025;272:606.
    

    >> Share

    
    
18. ASLAN D, Bourabia S, Kowall B, Straukiene A, et al
    The impact of autoimmune comorbidities on multiple sclerosis progression: insights from a longitudinal single-center study.
    J Neurol. 2025;272:607.
    

    >> Share

    
    
19. ELLENBERGER D, Frahm N, Stahmann A, Warnke C, et al
    Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis.
    J Neurol. 2025;272:609.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

20. AYSE YASAR, Esma Ebru Altun, Fatma Guliz Atmaca, Serife Ece Ulu, et al
    Hashimoto's thyroiditis in children and adolescents: analysis of long-term course.
    J Pediatr Endocrinol Metab. 2025 Sep 1. doi: 10.1515/jpem-2025-0320.
    

    >> Share

    
    

    
    J Rheumatol

21. CONSOLARO A, Ruperto N, Lovell DJ, Synoverska O, et al
    Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
    J Rheumatol. 2025;52:919-926.
    

    >> Share

    
    
22. JUNEK ML, Chanchlani R, Rodriguez AR, Khalidi N, et al
    Assessment of giant cell arteritis-associated visual outcomes at a tertiary hospital in Ontario, Canada.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0459. doi: 10.3899/jrheum.2025-0459.
    

    >> Share

    
    
23. ZAFFINO I, Boulard L, Law J, Danguecan A, et al
    Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0375. doi: 10.3899/jrheum.2025-0375.
    

    >> Share

    
    
24. LIN CH, Lin YP
    Classic Magnetic Resonance Imaging Features Unmask Progressive Multifocal Leukoencephalopathy in Rituximab-Treated Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0410. doi: 10.3899/jrheum.2025-0410.
    

    >> Share

    
    
25. HORN KW, Breneman A, Djavid AR, Boneparth AD, et al
    A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0367. doi: 10.3899/jrheum.2025-0367.
    

    >> Share

    
    

    
    Mult Scler

26. DERSCH R, Wiendl H
    'Anti-B cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation': Yes.
    Mult Scler. 2025 Aug 29:13524585251364140. doi: 10.1177/13524585251364140.
    

    >> Share

    
    
27. MASSEY J, Monif M
    Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? Commentary.
    Mult Scler. 2025 Aug 29:13524585251370085. doi: 10.1177/13524585251370085.
    

    >> Share

    
    
28. BRUNO A, Greco R
    Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? No.
    Mult Scler. 2025 Aug 29:13524585251364144. doi: 10.1177/13524585251364144.
    

    >> Share

    
    
29. TOUBASI AA, Graham M, Cutter G, Gheen C, et al
    Comparing the macromolecular-to-free pool size ratio and the magnetization transfer ratio for the assessment of myelin injury in early multiple sclerosis.
    Mult Scler. 2025 Sep 1:13524585251364766. doi: 10.1177/13524585251364766.
    

    >> Share

    
    
30. LI J, Hutton GJ, Aparasu RR
    Prevalence of multiple sclerosis and disease-modifying therapy use in older adults in the United States, 2011-2021.
    Mult Scler. 2025 Sep 2:13524585251368687. doi: 10.1177/13524585251368687.
    

    >> Share

    
    
31. LARONI A, Vigo T, Inglese M, Uccelli A, et al
    Immunosenescence in multiple sclerosis: New insights and clinical implications.
    Mult Scler. 2025 Sep 2:13524585251367611. doi: 10.1177/13524585251367611.
    

    >> Share

    
    

    
    N Engl J Med

32. CARLSSON PO, Hu X, Scholz H, Ingvast S, et al
    Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.
    N Engl J Med. 2025;393:887-894.
    

    >> Share

    
    
33. REICHMAN TW, Markmann JF, Odorico J, Witkowski P, et al
    Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
    N Engl J Med. 2025 Jun 20. doi: 10.1056/NEJMoa2506549.
    

    >> Share

    
    

    
    Nat Rev Neurol

34. CABALLERO-AVILA M, Pascual-Goni E, Lleixa C, Martin-Aguilar L, et al
    The changing landscape of primary autoimmune neuropathies.
    Nat Rev Neurol. 2025 Sep 5. doi: 10.1038/s41582-025-01133.
    

    >> Share

    
    

    
    Neurology

35. CORTESE R, Sforazzini F, Gentile G, de Mauro A, et al
    Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.
    Neurology. 2025;105:e214075.
    

    >> Share

    
    
36. RENNER B, Verter ED, Absinta M, Daboul L, et al
    Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic.
    Neurology. 2025;105:e213912.
    

    >> Share

    
    
37. CHARD DT
    Diagnosing Multiple Sclerosis: An Imperfect but Evolving Process.
    Neurology. 2025;105:e214057.
    

    >> Share

    
    

    
    PLoS One

38. GOEZ-MORA JE, Arbelaez-Cordoba N, Balcazar-Morales N, Rivadeneira PS, et al
    Validation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control.
    PLoS One. 2025;20:e0330121.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

39. MYKICKI N, Eble JA, Weighardt H, Gonnelli E, et al
    AhR signaling in skin-resident CD207(+) cells is involved in UV-B-induced amelioration of neuroinflammation.
    Proc Natl Acad Sci U S A. 2025;122:e2424009122.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share